Therapeutic targets associated to E-cadherin dysfunction in gastric cancer

By Carneiro Patrícia   Figueiredo Joana   Bordeira-Carriço Renata   Fernandes Maria Sofia   Carvalho Joana   Oliveira Carla   Seruca Raquel  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 10, 2013-10 ,pp. : 1187-1201

Informa Healthcare

Access to resources Recommend Favorite

The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1888-1895

Bentham Science Publishers

Access to resources Recommend Favorite

Enhancement of tamoxifen-induced E-cadherin function by Ca 2+ channel antagonists in human breast cancer MCF7/6 cells

By Charlier C.   Bruyneel E.   Lechanteur C.   Bracke M.   Mareel M.   Castronovo V.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 413-416

Elsevier

Access to resources Recommend Favorite

The Role of E-Cadherin Down-Regulation in Oral Cancer: CDH1 Gene Expression and Epigenetic Blockage

By  

Current Cancer Drug Targets, Vol. 14, Iss. 2, 2014-02 ,pp. : 115-127

Bentham Science Publishers

Access to resources Recommend Favorite

Posttranslational Truncation of E-Cadherin and Significance for Tumour Progression

By  

Cells Tissues Organs, Vol. 185, Iss. 1-3, 2007-06 ,pp. : 175-179

Karger

Access to resources Recommend Favorite